NGVT

The headline looks ugly — a -$167M net loss, -14.3% net margin and an absurd -562.6% ROE — but the income statement is being distorted by Ingevity's own restructuring. The ~$370M PC Repositioning program (≈$255M of it non-cash asset write-downs) is substantially complete ($353.7M of charges already taken through Dec 2025), and management says it has captured 'substantially all' of the anticipated $95-110M of savings. Strip the noise and the underlying business is healthy: 39.5% gross margin, 35.9% operating margin and $419M of operating income on $1.17B of revenue. Most tellingly, operating cash flow jumped 157.5% to $331M against just $57.7M of capex — roughly $270M of free cash flow, a ~10% FCF yield on the $2.61B market cap. That is not a broken company; it is a profitable one digesting a strategic overhaul.

The strategy is a deliberate retreat from low-margin, cyclical end-markets (adhesives, publication inks, oilfield — once ~45% of industrial specialties sales) toward higher-margin Performance Materials (automotive emissions-control carbon) and pavement technologies. The Jan 1, 2026 divestiture of the industrial specialties line and CTO refinery — now in discontinued operations — explains much of the optical revenue erosion from $1.67B (FY22) to $1.17B (FY25); some of that shrinkage is intentional pruning, not pure demand loss. A further review of the APT segment and road-markings line is underway, which could surface additional value or simplify the story.